Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Change in Inventory (2020 - 2025)

Historic Change in Inventory for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$1.3 million.

  • GeneDx Holdings' Change in Inventory fell 37924.53% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $526000.0, marking a year-over-year decrease of 7138.19%. This contributed to the annual value of $2.6 million for FY2024, which is 36512.82% up from last year.
  • Latest data reveals that GeneDx Holdings reported Change in Inventory of -$1.3 million as of Q3 2025, which was down 37924.53% from -$628000.0 recorded in Q2 2025.
  • GeneDx Holdings' 5-year Change in Inventory high stood at $9.8 million for Q1 2021, and its period low was -$7.6 million during Q4 2022.
  • Over the past 5 years, GeneDx Holdings' median Change in Inventory value was $454000.0 (recorded in 2024), while the average stood at $524000.0.
  • In the last 5 years, GeneDx Holdings' Change in Inventory surged by 39212.22% in 2023 and then crashed by 37924.53% in 2025.
  • Quarter analysis of 5 years shows GeneDx Holdings' Change in Inventory stood at $3.3 million in 2021, then crashed by 330.67% to -$7.6 million in 2022, then skyrocketed by 96.14% to -$293000.0 in 2023, then surged by 254.95% to $454000.0 in 2024, then plummeted by 393.39% to -$1.3 million in 2025.
  • Its Change in Inventory was -$1.3 million in Q3 2025, compared to -$628000.0 in Q2 2025 and $2.0 million in Q1 2025.